ABSTRACT
BACKGROUND: Visceral leishmaniasis (VL), or kala-azar, is a common comorbidity in patients with AIDS in endemic areas. Many patients continue to experiences relapses of VL despite virological control, but with immunological failure. These patients remain chronically symptomatic with hypersplenism, for example with anemia, leukopenia, and thrombocytopenia, and are at risk of severe co-infection due to low CD4+ count. Therefore, in this study, splenectomized patients with VL and HIV infection were investigated to understand why the CD4+ count fails to recover in these patients, evaluating the importance of spleen mass for hypersplenism and immunological failure. METHODS: From a retrospective open cohort of 13 patients who had previously undergone splenectomy as salvage therapy for relapsing VL, 11 patients with HIV infection were investigated. This study compared the patients' complete blood cell count (CBC) and CD4+ and CD8+ cell counts before and after splenectomy with respect to spleen weight. RESULTS: CBC was substantially improved after splenectomy, indicating hypersplenism. However, to the best of our knowledge, this is the first study to show that spleen mass is strongly and negatively correlated with CD4+ cell count (ρ = -0.71, P = 0.015). CONCLUSIONS: This finding was unexpected, as the spleen is the most extensive lymphoid tissue and T-lymphocyte source. After reviewing the literature and reasoning, we hypothesized that the immunological failure was secondary to CD4+ loss initially by apoptosis in the spleen induced by productive HIV infection and, subsequently, by pyroptosis sustained by parasitic infection in spleen macrophages.
Subject(s)
Acquired Immunodeficiency Syndrome , HIV Infections , Hypersplenism , Leishmaniasis, Visceral , Humans , Leishmaniasis, Visceral/epidemiology , HIV Infections/complications , Hypersplenism/complications , Retrospective Studies , Cemeteries , Acquired Immunodeficiency Syndrome/complications , Neoplasm Recurrence, Local/complications , CD4-Positive T-LymphocytesABSTRACT
In Latin America, the causative agent of kala-azar is the intracellular protozoan Leishmania infantum. Most cases in South America are reported in Brazil. Worldwide, it mainly affects Bangladesh, Ethiopia, India, South Sudan and Sudan. Despite the high morbidity and lethality of kala-azar, most infections are asymptomatic. However, a small portion of patients evolves with recurrence of kala-azar becoming symptomatic even after all available drug treatments. Kala-azar is not a formal indication for splenectomy in adults. Splenectomy is recommended as a saving measure, when kala-azar is associated with symptomatic hypersplenism and for drug-resistant cases. In the study, we report two cases of kala-azar with splenomegaly that presented several hospitalizations due to the recurrence of the kala-azar, in addition to hospitalizations for normalizing the blood count. After splenectomy, kala-azar cases and the effects of hypersplenism are cured. Thus, splenectomy should be seen as a surgical treatment option with a curative purpose in patients with recurrent kala-azar, in whom the possibilities of drug therapy have been exhausted and even so they progressed with hypersplenism and clinical repercussions.
Subject(s)
Leishmaniasis, Visceral/surgery , Adult , Humans , Male , Recurrence , Splenectomy , Treatment OutcomeABSTRACT
PURPOSE: To evaluate the effects of pre-conditioning with L-alanyl-glutamine (L-Ala-Gln) in rats subjected to total hepatic ischemia. METHODS: Thirty Wistar rats, average weight 300g, were randomly assigned to 3 groups (n=10): G-1--saline, G-2--L-Ala-Gln, G-3--control (Sham). G-1 and G-3 groups were treated with saline 2.0 ml or L-Ala-Gln (0.75mg/Kg) intraperitoneally (ip) respectively, 2 hours before laparotomy. Anesthetized rats were subjected to laparotomy and total hepatic ischemia (30 minutes) induced by by clamping of portal triad. Control group underwent peritoneal puncture, two hours before the sham operation (laparotomy only). At the end of ischemia (G1 and G2), the liver was reperfused for 60 minutes. Following reperfusion blood samples were collected for evaluation of alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) levels. Liver (medium lobe) was removed for immunohistochemistry study with antibody for Caspase-3. RESULTS: It was found a significant decrease (p<0.05) of ALT levels (270.6 +40.8 vs 83.3 +5.5 - p <0.05), LDH (2079.0 +262.4 vs. 206.6 +16.2 - p <0.05) and Caspase-3 expression (6.72 +1.35 vs. 2.19 +1.14, p <0.05) in rats subjected to I / R, comparing the group treated with L-Ala -Gln with G-2. Also, the ALT level was significantly lower (P<0.05) in G-1 and G-2 groups than in G-3 (control group). CONCLUSION: L-Ala-Gln preconditioning in rats submitted to hepatic I/R significantly reduces ALT, LDH and Caspase-3 expression, suggesting hepatic protection.
Subject(s)
Dipeptides/pharmacology , Ischemia/complications , Ischemic Preconditioning/methods , Liver/blood supply , Reperfusion Injury/prevention & control , Alanine Transaminase/blood , Animals , Disease Models, Animal , Immunohistochemistry , L-Lactate Dehydrogenase/blood , Liver/drug effects , Male , Random Allocation , Rats , Rats, Wistar , Time Factors , Treatment OutcomeABSTRACT
PURPOSE: To evaluate the effects of pre-conditioning with L-alanyl- glutamine (L-Ala-Gln) in rats subjected to total hepatic ischemia. METHODS: Thirty Wistar rats, average weight 300g, were randomly assigned to 3 groups (n=10): G-1 - Saline, G-2- L-Ala-Gln, G-3-control (Sham). G-1 and G-3 groups were treated with saline 2.0 ml or L-Ala-Gln (0.75mg/Kg) intraperitoneally (ip) respectively, 2 hours before laparotomy. Anesthetized rats were subjected to laparotomy and total hepatic ischemia (30 minutes) induced by by clamping of portal triad. Control group underwent peritoneal puncture, two hours before the sham operation (laparotomy only). At the end of ischemia (G1 and G2), the liver was reperfused for 60 minutes. Following reperfusion blood samples were collected for evaluation of alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) levels. Liver (medium lobe) was removed for immunohistochemistry study with antibody for Caspase-3. RESULTS: It was found a significant decrease (p<0.05) of ALT levels (270.6 +40.8 vs 83.3 +5.5 - p <0.05), LDH (2079.0 +262.4 vs. 206.6 +16.2 - p <0.05) and Caspase-3 expression (6.72 +1.35 vs. 2.19 +1.14, p <0.05) in rats subjected to I / R, comparing the group treated with L-Ala -Gln with G-2. Also, the ALT level was significantly lower (P<0.05) in G-1 and G-2 groups than in G-3 (control group). CONCLUSION: L-Ala-Gln preconditioning in rats submitted to hepatic I/R significantly reduces ALT, LDH and Caspase-3 expression, suggesting hepatic protection.
OBJETIVO: Avaliar os efeitos do pré-condicionamento com L-alanil-glutamina (L-Ala-Gln) em ratos submetidos à isquemia hepática total. MÉTODOS: Trinta ratos Wistar, peso médio 300g foram divididos aleatoriamente em três grupos (n = 10): G-1 - Saline, G-2: L-Ala-Gln, G-3: controle. G-1 e G-3 grupos foram tratados com 2,0 ml de solução salina ou L-Ala-Gln (0,75 mg / kg) intraperitoneal (ip), respectivamente, duas horas antes da laparotomia. Ratos anestesiados foram submetidos à laparotomia e isquemia hepática total (30 minutos) induzida por pinçamento da tríade portal. O grupo controle foi submetido à punção peritoneal, duas horas antes da operação simulada (apenas laparotomia). No final da isquemia, o fígado foi reperfundido por 60 minutos. As amostras de sangue foram colhidas ao término da reperfusão para determinação das concentrações alanina aminotransferase (ALT) e desidrogenase láctica (LDH). O lobo médio do fígado foi removido para estudo imuno-histoquímico com anticorpo para caspase-3. RESULTADOS: Houve diminuição significante (p<0.05) dos valores de ALT (270,6+40,8 vs 83,3+5,5 - p<0,05), LDH (2079,0+262,4 vs 206,6+16,2 - p<0,05) e expressão da Caspase-3 (6,72+1,35 vs 2,19+1,14 -p<0,05) nos ratos submetidos à I/R, comparando o grupo tratado com L-Ala-Gln, ao grupo salina. Além disso, o nível de ALT foi significativamente menor (P <0,05) no G-1 e G-2 do que no grupo G-3 (grupo controle). CONCLUSÃO: O pré-condicionamento com L-Ala-Gln em ratos submetidos a I/R hepática reduz significativamente as concentrações de ALT e LDH e a expressão da caspase-3, sugerindo proteção hepática.
Subject(s)
Animals , Male , Rats , Dipeptides/pharmacology , Ischemia/complications , Ischemic Preconditioning/methods , Liver/blood supply , Reperfusion Injury/prevention & control , Alanine Transaminase/blood , Disease Models, Animal , Immunohistochemistry , L-Lactate Dehydrogenase/blood , Liver/drug effects , Random Allocation , Rats, Wistar , Time Factors , Treatment OutcomeABSTRACT
Anormalidades do úraco em adultos säo incomuns. Os autores apresentam um caso de úraco persistente em edulto e fazem revisäo da embriologia e anatomia do úraco enfatizando apresentaçäo clínica, evoluçäo e tratamento.
Subject(s)
Humans , Male , Adult , Urachus/abnormalitiesABSTRACT
Foram castrados exemplares machos de Rattus novergicus em idade pós-púbere para avaliar o efeito dos androgênios sobre a eritropoiese. O volume globular foi monitorado por treze dias. O grupo controle de machos mostrou uma média de 45,16 ñ 0,75%, o grupo controle de fêmeas 44,21 ñ 0,97%, o grupo experimental de machos castrados 41,25 ñ 1,25% (p<0,05) no sexto dia e 42,80 ñ 0,80% no décimo terceiro dia (p<0,05); o grupo exerimental de castrados ñ 1,25% (p<0,05) no sexto dia e 42,80 ñ 0,80% no décimo terceiro dia (p<0,05); o grupo experimental de castrados tratados com testosterona apresentou um média de 43,40 ñ 1,47% no décimo terceiro dia pós-castraçäo. Esses achados mostram a importância dos androgênios na eritropoiese
Subject(s)
Rats , Animals , Male , Female , Androgens/metabolism , Castration , Erythropoiesis/physiology , Blood Volume/physiologyABSTRACT
A tireoidite subaguda é uma afecçäo que freqüentemente é confundida com patologia de orofaringe, e assim é tratada levando os pacientes a um sofrimento possível de ser evitado. Nesta série de casos mostramos uma abordagem simples de diagnóstico e tratamento
